Africa CDC Centres for Disease Control and Prevention
40
Organisation Mondiale de la Santé OMS
39
Centers for Disease Control and Prevention CDC
38
Organización Mundial de la Salud OMS
38
et al.
33
UNICEF
33
World Health Organization (WHO)
32
World Health Organisation (WHO)
31
Pan American Health Organisation PAHO
26
Pan American Health Organization PAHO, World Health Organization WHO
25
OPAS
21
Всемирная организация здравоохранения (ВОЗ)
19
Robert-Koch-Institut RKI
18
World Health Organization WHO, Regional Office of Europe
17
International SOS
16
Всемирная организация здравоохранения (Eвропейское)
16
Reliefweb
14
IFRC
13
Organisation Mondiale de la Santé (OMS)
13
Organisation Mondiale de la Santé OMS
13
European Centre for Disease Prevention and Control ECDC
12
WHO
12
IASC Reference Group on Mental Health and Psychosocial Support in Emergency Settings
11
UN Children's Fund UNICEF
11
OCHA Services
10
European Centre for Disease Prevention and Control ECDC
9
Ministerio de sanidad - España
9
World Health Organisation
9
World Health Organization (Europe)
9
ВОЗ
9
Africa CDC Centers for Disease Control and Prevention
8
Africa CDC Centres for Disease Control and Prevention (Safeguarding Africa's Health)
8
Organização Mundial da Saúde (OMS)
8
UNAIDS
8
Всемирная организация здравоохранения
8
Ministerio de Salud, Peru
7
Global Handwashing Partnership
6
World Health Organization WHO, Regional Office of Africa
6
CDC
5
Ministerio de Salud El Salvador
5
Ministerio de Salud Pública de Ecuador
5
Ministerio de Salud y Protección Social Bogotá, Colombia
5
OPS
5
Organización Mundial de Saude and OPAS
5
Pan American Health Organization (PAHO), OPS
5
Pan American Health Organization PAHO
5
Regional Office for Africa
5
USAID
5
Всемирная Организация Здравоохранения - Европейское региональное бюро
5
Министерство здравоохранения Российской Федерации
5
Africa Centres for Disease Control and Prevention (Africa CDC)
4
African Union, Africa CDC
4
Centro de Coordinación de Alertas y Emergencias Sanitarias
4
Centro de Coordinación de Alertasy Emergencias Sanitarias
4
Government of India
4
Kamps, B.S.
4
Ministerio da Saude, Brasilia
4
Ministerio de Salud Argentina
4
Ministerio de Salud Bolivia
4
Ministerio de Salud Chile
4
Ministério da Saúde, Brasil
4
Ministry of Health & Family Welfare
4
Regional Office for the Eastern Mediterreanan
4
World Health Organisation WHO
4
Africa CDC
3
AMREF
3
and C. Hoffmann
3
ASLM
3
Clinical Care Options
3
Eastern Mediterranean Region
3
Health Emergencies Programme
3
Inter-agency Working Group on Reproductive Health in CrisesInternational Rescue Committee
3
International Committee of the Red Cross ICRC
3
International Federation of Red Cross and Red Crescent Societies IFRC
3
Mauder, S.
3
Ministerio de Salud Publica Paraguay
3
Ministério da Saúde, Brazil
3
Ministério da Saúde, Secretaria de Atenção Primária à Saúde Brasil
3
OCCHA Services
3
OCHA
3
OPAS, OMS
3
Organisation Mondiale de la Santé
3
Organización Panamericana de la Salud
3
World Health Organization
3
World Health Organization WHO
3
World Health Organization WHO, et al.
3
World Health Organsiation WHO
3
AFEM African Federation For Emergency Medicine
2
and P. Reijer
2
Apotheker ohne Grenzen und Brot für die Welt
2
BMJ
2
BMJ Global Health
2
Bundesministerium für Gesundheit BMGS und BzGA
2
C. Ferreira-Borges
2
Caroline Favas
2
Centre for Respiratory Diseases and Meningitis and Outbreak Response
2
Communication for Devleopment4 Network
2
Department: Health Republic of South Africa
2
DIFÄM
2
Dr. J. Breda
2
European Centers for Disease Control and Prevention ECDC
2
F. P. Soruco Marc et al.
2
Family Larsson
2
FHI 360
2
Flores Conde, F.
2
Health Emergency Programme
2
Inter-Agency Standing Committee IASC
2
Internews
2
Istituto Superiore di Sanità (ISS)
2
Knowledge Translation Unit (University of Cape Tow Lung Institute)
2
Lancet Migration
2
London School of Hygiene and Tropical Medicine
2
M. Dara
2
MEDBOX
2
Ministerio da Saude Brasilia
2
Ministerio de Salud y Deportes Bolivia
2
Ministério da Saúde
2
Ministry of Health & Family Welfare Government of India
2
Ministry of Health and Family Welfare, Government of India
2
Ministry of Health, Kenya
2
National Centre for Disease Control (formerly National Institute of Communicable Diseases)
2
National Department of Health, South Africa
2
National Environment Agency (Safeguard-Nurture,Cherish)
2
Organización Mundial de la Salud (Américas)
2
PAHO
2
Pan American Health Organisation PAHO, et al.
2
Practical Approach to Care Kit (PACK)
2
Rosenquist Foundation (dedicated to human milk)
2
See text
2
Smithsonian Science Education Center
2
Smithsonian Science Education Center, et al.
2
Stop TB Partnership
2
the Inter-Agency Standing Committee’s Mental Health and Psychosocial Support Reference Group
2
The Sanitation Learning Hub
2
UN High Commissioner for Refugees UNHCR
2
UNFPA
2
UNHCR
2
UNICEF and GOARN
2
Unidad de vigilancia de la Salud, Gobierno de la répubica de Honduras
2
Union Africaine
2
University of Cape Town
2
WHO (World Health Organisation)
2
WHO Regional Office for Europe
2
World Health Organization & United Nations Children's Fund (UNICEF).
2
World Health Organization WHO, Regional Office for Europe
2
World Health Organization WHO, IFRC
2
1mg
1
A. Agodi
1
A. Tausch
1
A.Goncé, A. Hawkins-Villarreal et al.
1
Abdul Rahim, H.F.
1
Abir, T.
1
Accreditation Counci for Continuing Medical Education
1
ACPF, Plan International
1
Adelekan, B.
1
AFP Fact check
1
Africa CDC Centres for Disease Control and Prevention (
1
Africa Centres for Disease Control and Prevention Center for Disease , African CDC
1
African Union UN Human Rights Council
1
AIDS Education Training Center AETC
1
ALNAP
1
Ana Flor Hexel Cornely, João Gabriel Flôres da Rocha
1
Anaya-Covarrubias, J.Y.
1
and C. Wonodi
1
Antimicrobial Therapy
1
B. Ezenwa
1
B. N. Ezenwa, I. B. Fajolu, O. R. Akinajo, et al.
1
B.S. Kamps
1
Bagattini AM, de Melo Tavares B, Garcia Moraes Pagano C, et al.
1
Bapoutou, B.
1
Barasa, E.
1
Barcelos TN, Muniz LN, Dantas DM et al.
1
Bender L.
1
Berger, S.
1
Bham A., J. Bhiman, F. Bongweni et al.
1
Bham, A.
1
Biancovilli, p.
1
Bio Med Central
1
BioNTech
1
BMC Public Health
1
Bolivia, Ministerio de Salud, Gobierno de Estado Plurinacional s
1
Breathrough Action - For social and behavior change
1
British Medical Journal
1
BVÖGD, bvmd
1
C. Clift
1
C. Hoffmann, et al.
1
Caqueo-Urízar A., Urzúa A. et al
1
Castillo C., Villalobos Dintrans P. et al
1
Centre Africain de contrôle et de prévention des maladies (CDC Afrique)
1
Centre for Respiratory Diesease and Meningitis, South Africa
1
Centre for Rural Health (CRH)
1
Centro Africano de prevenção e luta contra doenças
1
Centros de controle e prevenção de doenças de Àfrica (África CDC)
1
CERAH
1
Charité Berlin
1
Chen Shen, Nan Xia, et al.
1
Child Protection Cluster
1
Chu, D.K.
1
Clinical Drug Information, Inc. and its affiliates and
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Cobas
1
Collective Service RCCE
1
compass
1
Corman, V.
1
COVID-19 Mental Disorders Collaborators
1
Cullen M.
1
Cupertino, M. C.
1
D. Antognini, A. Combes, et al.
1
Departamento de Gestão e Incorporação de Tecnologias e Inovação em Saúde – DGITIS
1
Department for International Development DFID
1
Department of Health & Family Welfare Government of Kerala
1
Dept. of Psychiatry
1
Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V.
1
DGS
1
DGVS Paraguay
1
Dheda, K.
1
Dirección de Control de Enfermedades Inmunoprevenibles
1
DIRECCIÓN GENERAL DE SALUD PÚBLICA, CALIDAD E INNOVACIÓN
1
Dirección General de Vigilancia de la Salud (DGVS)
1
Direction de la conte lutte contre la maladie les épidémies et les pandémies
1
Direction générale de la prevention et de la promotion de la santé
1
Divya Nair, Nisha Hariharan, Raghav Adlakha, et al.
1
Doubova SV, Leslie HH, Kruk ME, et al.
1
Dr. Anna-Maria von Rod
1
Dr. P. Abraham
1
Dr. P. Amoth
1
Dr. S. K. Kibias
1
Dr. V. Potdar
1
Dr. Y.K. Gurav
1
Dra. Ximena Garzón et al.
1
E. Goldson, Z. Abubakar et al.
1
E. Ross
1
E.A Akl, S. Duda, et al.
1
E.Schuler
1
El Gobierno des Todos, Ecuador
1
Emelurumonye I. N., A. Miglietta
1
Epidemiologisches Bulletin
1
Equipo Humanitaria de Pais Guatemala
1
et al
1
Ethiopian Food and Drug Authority
1
European specialist nurse organisation (ESN)
1
Eurosurveillance
1
F. “P.” D’Ancona
1
Faella O. M., Cardozo M. A. et al.
1
Fajolu, I.
1
Feng,S.
1
Ferres M., Potin M.
1
Food and Agriculture Organization (FAO)
1
Food and Agriculture Organization of the United Nations
1
Food for the Hungry et al.
1
Foundation for Innovative and New Diagnostics
1
Frontiers in Public Health
1
Garcia, P.J.
1
Geffert,K., N. Rupp und S. Mauder
1
GeoPoll
1
Gideon
1
Gilman, R.T.
1
Global Mental Health
1
Global Nutrition Cluster
1
Global Polio Eradication Initiative (GPEI
1
Goodman, T.
1
Government of India Ministry of Health & FW
1
Government of Libya, World Health Organization (WHO)
1
Government of Malawi
1
Government of Nigeria
1
Greinacher, A., et al.
1
Gribble RSF, Liese BH, Wickremsinhe MN
1
Haldane, V., De Foo, C., Abdalla, S.M. et al.
1
Haute Conseil de la Santé Publique
1
Health Cluster
1
Health Cluster & Shelter Cluster Iraq
1
health Department: Health Republic of South Africa
1
Health Protection Surveillance Centre (HSE)
1
Health Sector Cox Bazar
1
Health Sector Syria
1
Helen Keller International
1
Hoffmann, C.
1
Honein MA, Christie A, Rose DA, et al.
1
hpsc
1
Hussein Ahmed
1
IFRC - International Federation of Red Cross
1
IFRC Reference Centre for Psychosocial Support
1
IFRC, UNICEF and WHO
1
iMMAP
1
Imperial College COVID-19 Response Team
1
India COVID-19 Emergency Response and Health Systems Preparedness Project (P173836)
1
Indian Council of Medical Research (icmd)
1
Infection Prevention and Control UHL, WHO Headquarters
1
Insfran J. D. M., Vicioso J. J. R. et al.
1
Instituto Nacional del Cancer and Ministerio de Salud, Argentina
1
Inter Agency Standing Committee
1
Inter-Agency Standing Comittee IASC
1
Inter-Agency Standing Committee IASC, et al.
1
Inter-American Development Bank IDB
1
International Federation of Red Cross and Red Crescent Societies
1
International Pharmaceutical Federation (FIP)
1
Irarrazaval M., Norambuena P. et al
1
ISARIC
1
J. Bhiman, F. Bongweni et al.
1
Jara A., Undurraga E. A. et al
1
Jassat, W.
1
Jésuites d'Afrique de l'Ouest
1
John Hopkins Bloomberg School
1
Julián-Jiménez, A.
1
K. Doerholt
1
K. Khalid, A.Wharton-Smith, et al.
1
K. Tolksdorf
1
Kaloti R., R. Kafri, H. Meghari
1
KEMRI-Wellcome Trust Research Programme and African Academy of Sciences
1
KfW Development Research
1
Kim, A.
1
Kluge, S. et al.
1
Knoll, M.D.
1
Kuate, L.M. et al.
1
Kuehn, B.M.
1
L. Bertinato
1
L. Cai
1
L. Makszin and C.Jurberg
1
Le centre Africain de prévention et de lutte contre la maladie (CDC Afrique)
1
Leibtag, S.
1
Logunov, D.Y, et al.
1
LSHTM
1
M. Ballard, Bancroft E., Nesbit J., et al.
1
M. Fendt-Newlin, S. T. Al-Harahsheh, et al.
1
M. Langer
1
M. Nebuloni
1
M. S. Razai
1
M. V. Larico Rojas
1
Makwe, C.
1
Martinez Viciana, C.
1
Martinez-Portilla r.J.
1
Marty, F.M.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Mauder S., Geffert K.
1
Military Medical Research
1
Ministere de la Santé Publique
1
Ministerio da Saude Brasilia, Centro Colaborador do SUS
1
Ministerio da Saude do Brasil
1
Ministerio de Salud y Deportes Bolivia
1
Ministerio de Salud Pública del Ecuador
1
Ministerio de Salud Pública y Bienestar Social (MSPBS), Paraguay
1
Ministerio de Salud Pública, Paraguay
1
Ministerio de Salud, Bogota, Colombia
1
Ministerio der Salud Argentina
1
Ministero della Salute
1
Ministère de la Santé de la population et de la réforme hospitalière
1
Ministrerio das Saude do Brasil
1
Ministry of Health
1
Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division)
1
Ministry of Health & Family Welfare of Bangladesh, Directorate General of Health Services
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health Singapore
1
Ministry of Health, Federal Democratic Republic of Ethiopia
1
Ministry of Health, Singapore
1
Ministry pf Health and Sanitation Sierra Leone
1
N. Petrosillo
1
Naciones Unidas Derechos Humanos
1
Nation Institute for Communicable Diseases, South Africa
1
National Department of Health Directorate: Communicable Diseases
1
National Department of Health South Africa
1
National Health Mission
1
National Institute for Viral Disease Control and Prevention, China
1
National Institute of Mental Health & Neurosciences, Bengaluru India
1
National Institute of Virology (NIV)
1
NCTSN
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
New England Journal of Medicine
1
Nganou-Gnindjio, C.N.
1
Niederberger,E.
1
Nigeria Centre of Disease Control
1
NSW Government, Ministry of Health
1
nter-Agency Standing Committee IASC
1
Nữ tu Bác sĩ Nguyễn Thị Hiền
1
O. M. Драпкина, Л. Ю. Дроздова,В. А. Егоров et al.
1
OHCHR
1
Oliveira e Souza, R.
1
OMS
1
OMS (WHO)
1
Open WHO
1
Organisation Mondiale de la Santé OMS, IFRC
1
Organisation mondiale de Santé
1
Organisation Mondiale de la Santé, Bureau régional de l'OMS pour l'Afrique
1
Organización Mundial de la Salud
1
Organización Mundial de la Salud (OMS)
1
Organización Mundial de la Salud OMS, IFRC
1
Organização Pan-Americana da Saúde
1
Oxfam
1
PACK
1
Pan American Health Organisation PAHO, OPS
1
Pan American Health Organization
1
Pan American Health Organization (PAHO)
1
Paul-Ehrlich-Institu PEI
1
Páez, L.S.
1
PERC
1
Pfizer
1
Plataforma Clínica Global da OMS para COVID-19
1
Polack, F.P. et al.
1
Polio Global Eradication Initiative
1
Psychosocial Centre
1
Quatar Foundation
1
R. D. Blacutt Paniagua
1
Rahman-Shepherd, A.
1
Ramanathan, K.
1
RCCE Collective Service
1
Regierung Unterfranken
1
Regional Office for Africa, Government of Mauritius
1
Repoductive Health Journal
1
Republic of India Ministry of Health and Family Welfare
1
Republic of Kenya Ministry of Health
1
Republic of South Sudan
1
Resende, M. B.
1
Reusken C. B. E. M., E. K. Broberg, B. Haagmans et al.
1
Rev Panam de Salud Pública
1
République Algérienne Démocratique et Populaire
1
République de Cameroun
1
Ricardo Heinzelmann, Rogerio Luz Coelho Neto et al.
1
Robert Koch Institut (RKI)
1
Roberton, T.
1
Roca de Sangüeza, M.A.
1
Rude, B.
1
Ruiz-Postigo, J.A.
1
S. Brünink
1
S. Buda
1
S. Ladhani
1
S. Mahroof-Shaffi, C. Harkensee, A.T Chamberlain
1
S. Novoa, B. Nieto et al.
1
S.R. Lewin and R. Sherer
1
Saiful Islam M. , Mizanur Rahman K., Sun Y., et al.
1
salud
1
Save the Children
1
Schell, C.O.
1
Schueller, E.
1
Secretaria de Atencao Primaria Saude (SAPS)
1
Secretaria Municipal de Saúde do Rio de Janeiro
1
SEGO, SAC Ecuador
1
Segvia, E. V. L. et al.
1
Servicio de Infectología Clínica–Instituto de Medicina Tropical
1
Servizio Sanitario Regionale Emilia-Romagna
1
Social Science in Humanitarian Action
1
Sociedad ecuatoriana de geriatria y gerontologia
1
Sociedade Brasileira de Medicina de Família e Comunidade
1
Societé francaise d'anesthésie et de réanimation SFAR
1
Springer Medizin Verlag GmbH
1
Stanford Guide
1
SUBPAV, SMS-Rio
1
Suicide Prevention Resource Center
1
System Socio Sanitario Regione Lombardia ATS Milano Città Metropolitana
1
T. Bleicker
1
T. Fernández Dávil, P. A. Hidalgo Andrade, F. G. Torres Toala et al.
1
Tegally, H.
1
TelessaudeRS, Ministerio da Saude Brasil
1
Temgoua, M.N.
1
The Center For Disease Dynamics, Economics & Policy
1
The Chatham House
1
The Global Health Network
1
The Independent Panel
1
The International Federation of Red Cross and Red Crescent Societies IFRC
1
The Journal of Maternal-Fetal & Neonatal Medicine
1
The Lancet
1
The National Child Traumatic Stress Network
1
The Partnership Center
1
The World Bank
1
The World Bank, unicef, World Food Programme et al.
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...placing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).more
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...ies (4). Vaccination has substantially reduced case numbers and hospitalizations in many countries,but limitations in global access to vaccines mean that many populations, including those in low- and middle-income countries, remain vulnerable. Even in vaccinated individuals, uncertainties remain about duration of protection and efficacy, and the degree of crossprotection with new variants.
There remains a need for more effective treatment and management for those affected by COVID-19. The pandemic – and the
explosion of both research and misinformation – has highlighted the need for trustworthy, accessible and regularly updated living
guidelines to place emerging findings into context and provide clear recommendations for clinical practicemore
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...and risk factors
that lead to post COVID-19 condition, along with its impact on everyday functioning and development of
children and adolescents. Long-term outcomes of the condition are currently unknown and need to be
studied. For these reasons, a globally standardized clinical case definition is needed.
Aim: To develop a globally relevant standardized clinical case definition for children and adolescents by
building on the WHO clinical case definition for post COVID-19 condition in adults.more
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method...ology issues there are still insufficient data to make a recommendation, in which case different options for approaching VE evaluations are presented.more
an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national and local levels, 14 March 2022
This second edition of the Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline provides the most up to date technical guidance on mask use in community settings in the context of COVID-19.
In this edition, new information includes updated mask re...commendations for children in community settings including updated age specific recommendations, statements for children with disabilities and those at high risk for complications related to COVID-19 infection. Updated implementation considerations for mask use in school settings are also included.
This living guideline is being published using the MAGICApp online publishing platform https://app.magicapp.org/#/guideline/Lr2a8L , as well as in PDF copy on the WHO website.more
Countries reported disruptions in all health-care settings. In more than half of countries surveyed, many people are still unable to access care at the primary care and community care levels. Significant disruptions have also been reported in emergency care, particularly concerning given the impact... on people with urgent health needs. Thirty-six per cent of countries reported disruptions to ambulance services; 32% to 24-hour emergency room services; and 23% to emergency surgeries.
Elective surgeries have also been disrupted in 59% of countries, which can have accumulating consequences on health and well-being as the pandemic continues. Disruptions to rehabilitative care and palliative care were also reported in around half of the countries surveyed.
Major barriers to health service recovery include pre-existing health systems issues which have been exacerbated by the pandemic as well as decreased demand for care.more
The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19.
The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID...-19: living guideline published on the 14 January 2022 and the third version of the WHO COVID-19 Clinical management: living guidance published on the 23 November 2021.more
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...s and lessons learned as countries adapted their influenza surveillance systems in the context of the COVID-19 pandemic and reviews new evidence to provide guidance on end-to-end surveillance. The guidance includes new algorithms and strategies to adapt sentinel systems to make them resilient and agile for addressing global and national surveillance needs for influenza and COVID-19.covid-more
22 April 2022, This document provides updated interim recommendations on the use of masks by health workers providing care to patients with suspected or confirmed COVID-19. This update is prompted by new evidence around mask use and COVID-19 transmission, as well as the emergence of variants of conc...ern including Omicron. Masks continue to be a critical tool to prevent the spread of COVID-19. These interim guidelines supersede the recommendations provided in the WHO recommendations on mask use by health workers, in light of the Omicron variant of concern published on 22 December 2022.
WHO continually evaluates the emerging evidence and will review these interim recommendations within two months and issue new guidance as needed.more
Die WHO hat mit Hilfe der Delphi-Methode eine klinische Falldefinition für das Post-COVID-19-Syndrom entwickelt, die 12 Domänen umfasst und in allen Bereichen verwendet werden kann. Diese erste Version wurde von Patienten, Forschern und anderen Personen aus allen WHO-Regionen entwickelt, wobei dav...on ausgegangen wird, dass sich die Definition ändern kann, wenn sich neue Erkenntnisse ergeben und sich unser Verständnis der Folgen von COVID-19 weiterentwickelt.
Die Post-COVID-19-Erkrankung tritt bei Personen mit einer wahrscheinlichen oder bestätigten SARS-CoV-2-Infektion in der Anamnese auf, in der Regel drei Monate nach dem Auftreten von COVID-19 mit Symptomen, die mindestens zwei Monate anhalten und nicht durch eine andere Diagnose erklärt werden können. Zu den häufigen Symptomen gehören Müdigkeit, Kurzatmigkeit, kognitive Störungen, aber auch andere Symptome, die sich im Allgemeinen auf das tägliche Leben auswirken. Die Symptome können nach der anfänglichen Genesung von einer akuten COVID-19-Episode neu auftreten oder nach der ersten Erkrankung fortbestehen. Die Symptome können auch schwanken oder im Laufe der Zeit wieder auftreten.more
L'OMS a développé une définition de cas clinique de l'état post COVID-19 par la méthodologie Delphi qui comprend 12 domaines, disponible pour une utilisation dans tous les contextes. Cette première version a été élaborée par des patients, des chercheurs et d'autres personnes, représentant... toutes les Régions de l'OMS, étant entendu que la définition peut changer à mesure que de nouvelles preuves apparaissent et que notre compréhension des conséquences de la COVID-19 continue d'évoluer.
L'état post COVID-19 survient chez les personnes ayant des antécédents d'infection probable ou confirmée par le CoV-2 du SRAS, généralement 3 mois après l'apparition de symptômes qui durent au moins 2 mois et ne peuvent être expliqués par un autre diagnostic. Les symptômes courants comprennent la fatigue, l'essoufflement, le dysfonctionnement cognitif mais aussi d'autres et ont généralement un impact sur le fonctionnement quotidien. Les symptômes peuvent être d'apparition récente après le rétablissement initial d'un épisode aigu de COVID-19 ou persister depuis la maladie initiale. Les symptômes peuvent également fluctuer ou rechuter au fil du temps.more
Временные рекомендации25 июня 2021 г.
Данный документ представляет собой обновленное
издание рекомендаций «Принципы помещения в
карантин отдельных лиц в контекст... сдерживания
коронавирусного заболевания (COVID-19)»,
опубликованных 19 марта 2020 г. Действие
рекомендаций, представленных в этой версии документа,
распространяется только на случаи карантина для лиц,
которые контактировали с пациентами, имеющими
подтвержденный или вероятный диагноз COVID-19.
В документе содержатся обновленные рекомендации по
реализации карантинных мер, а также дополнительные
рекомендации в отношении вентиляции, а также ухода
за детьми, находящимися на карантине. В основу
данного обновленного издания положены фактические
данные о контроле за распространением вируса
SARS-CoV-2, являющегося возбудителем заболевания
COVID-19, и научные сведения об этом вирусе.more
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...y change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.more